AU2001253070A1 - Isoflavones for treatment of obesity - Google Patents
Isoflavones for treatment of obesityInfo
- Publication number
- AU2001253070A1 AU2001253070A1 AU2001253070A AU5307001A AU2001253070A1 AU 2001253070 A1 AU2001253070 A1 AU 2001253070A1 AU 2001253070 A AU2001253070 A AU 2001253070A AU 5307001 A AU5307001 A AU 5307001A AU 2001253070 A1 AU2001253070 A1 AU 2001253070A1
- Authority
- AU
- Australia
- Prior art keywords
- isoflavones
- obesity
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19346300P | 2000-03-31 | 2000-03-31 | |
US60193463 | 2000-03-31 | ||
PCT/US2001/010560 WO2001074345A2 (en) | 2000-03-31 | 2001-03-30 | Isoflavones for treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001253070A1 true AU2001253070A1 (en) | 2001-10-15 |
Family
ID=22713739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001253070A Abandoned AU2001253070A1 (en) | 2000-03-31 | 2001-03-30 | Isoflavones for treatment of obesity |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020010141A1 (en) |
AU (1) | AU2001253070A1 (en) |
WO (1) | WO2001074345A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050037100A1 (en) * | 1998-03-19 | 2005-02-17 | Bionorica Ag | Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic |
EP1281392A1 (en) * | 2001-08-02 | 2003-02-05 | Cognis France S.A. | Cosmetic or/and pharmaceutical compositions containing plant extracts |
DE10146159A1 (en) * | 2001-09-19 | 2003-04-10 | Bionorica Ag | Use of extracts from Cimicifuga species as an organ-selective drug for the treatment of sex hormone-dependent diseases of the urogenital tract |
US20050090457A1 (en) * | 2002-02-15 | 2005-04-28 | N.V. Nutricia | Method of treating mammals with genistein and/or genistein analogues |
DE10206390A1 (en) * | 2002-02-15 | 2003-08-28 | Bionorica Ag | Use of phytoestrogen-containing extracts that selectively modulate the estrogen receptor beta |
AUPS104402A0 (en) * | 2002-03-12 | 2002-04-11 | Redfern Optical Components Pty Ltd | Multi-layered structure characterisation |
FR2841470B1 (en) * | 2002-06-27 | 2006-01-13 | Pharmascience Lab | USE OF ISOFLAVONES FOR THE PREPARATION OF TOPICAL COMPOSITIONS USEFUL FOR PROMOTING SLIMMING AND ASSOCIATED COSMETIC TREATMENT METHOD |
US8580846B2 (en) * | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
US20040097429A1 (en) * | 2002-11-18 | 2004-05-20 | Nieuwenhuizen Arie Gijsbert | Method for the reduction of the mammalian appetite |
KR100994632B1 (en) * | 2002-12-27 | 2010-11-15 | (주)아모레퍼시픽 | Screening method of controlling agent for expression of CPT-1 gene, and CPT-1 expression enhancer comprising genistein which is screened by the method |
KR100520408B1 (en) * | 2003-03-25 | 2005-10-10 | 주식회사 태평양 | Compositions for the improvement of obesity |
JP2006524236A (en) * | 2003-04-24 | 2006-10-26 | アモレパシフィック コーポレーション | Slimming composition |
BRPI0508936A (en) * | 2004-03-17 | 2007-09-25 | Nestec Sa | compositions and methods for reducing or preventing obesity |
US20060039971A1 (en) * | 2004-08-19 | 2006-02-23 | Lee Robert E | Effervescent composition including alternative hormone replacement therapy agent |
CN100482243C (en) * | 2005-03-07 | 2009-04-29 | 骏神生物医学(上海)有限公司 | Application of olecranone bean extraction in preparation of food for preventing and treating obesity and type II diabetes |
EP1889638A4 (en) * | 2005-03-07 | 2008-04-02 | Jumpsun Bio Medicine Shanghai | Medicaments and food for treatment or prevention of obesity and/or diabetes containing cicer arietinum extract |
EP1956923A1 (en) * | 2005-11-02 | 2008-08-20 | Nestec S.A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
US8367072B2 (en) * | 2006-12-08 | 2013-02-05 | Polifenoles Naturales, S.L. | Composition for treating obesity and method of using the same |
FR2999080B1 (en) * | 2012-12-11 | 2015-03-20 | Isp Investments Inc | COSMETIC USE OF THE ASSOCIATION OF CARBOHYL AND CAFFEINE GERM EXTRACT AS A SLIMMING ACTIVE AGENT |
US10842809B2 (en) | 2016-12-16 | 2020-11-24 | Hills Pet Nutrition, Inc. | Pet food compositions |
US20240085431A1 (en) * | 2022-09-13 | 2024-03-14 | Société des Produits Nestlé S.A. | Methods for providing and determining an efficacious weight loss diet for a canine |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3864362A (en) * | 1970-05-27 | 1975-02-04 | Chinoin Gyogyszer Es Vegyeszet | Iso flavones |
GB1351880A (en) * | 1971-10-20 | 1974-05-01 | Chinoin Gyogyszer Es Vegyeszet | Metabolism-regulating derivatives |
DE69333624T2 (en) * | 1992-05-19 | 2005-09-15 | Novogen Research Pty. Ltd., North Ryde | USE OF ISOFLAVON PHYTO-ESTROGEN EXTRACTS OF SOY OR CLOVER |
NZ331691A (en) * | 1996-04-09 | 1999-10-28 | Isoflavone-enriched soy protein product and method for its manufacture | |
AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
JP2829387B2 (en) * | 1996-09-13 | 1998-11-25 | 農林水産省四国農業試験場長 | Composition for promoting lipolysis in fat cells |
JPH11116487A (en) * | 1997-10-11 | 1999-04-27 | Chin Tadahide | Material for normalizing blood sugar |
EP1027045A4 (en) * | 1997-10-31 | 2004-12-08 | Arch Dev Corp | Methods and compositions for regulation of 5-alpha reductase activity |
JPH11228430A (en) * | 1998-02-20 | 1999-08-24 | Asahi Breweries Ltd | Lipolysis promoter |
EP1037590B1 (en) * | 1998-07-16 | 2004-04-14 | Aaron Tabor | Soy formulations and their use for promoting health |
BR0008449A (en) * | 1999-02-24 | 2002-05-14 | Geza Bruckner | Dietary composition and method to reduce weight gain |
FR2803747B1 (en) * | 2000-01-18 | 2003-12-26 | Pharmascience Lab | USE OF ISOFLAVONES AND / OR EXTRACTS OF AFRICAN PLUM IN PHARMACY, COSMETICS AND AS A FOOD ADDITIVE. |
-
2001
- 2001-03-30 AU AU2001253070A patent/AU2001253070A1/en not_active Abandoned
- 2001-03-30 US US09/821,750 patent/US20020010141A1/en not_active Abandoned
- 2001-03-30 WO PCT/US2001/010560 patent/WO2001074345A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001074345A2 (en) | 2001-10-11 |
WO2001074345A3 (en) | 2002-03-21 |
US20020010141A1 (en) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001253070A1 (en) | Isoflavones for treatment of obesity | |
AU2002223827A1 (en) | Well treatment | |
AU2002257936A1 (en) | Methods of well treatment | |
AU2001233081A1 (en) | Composition for treatment of stress | |
AU2001286983A1 (en) | Method of treatment | |
AU2002324201A1 (en) | Waste treatment | |
AU2001277534A1 (en) | Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity | |
AU2003264673A1 (en) | Use of isoflavones for promoting slimming | |
AU2002330095A1 (en) | Flavonoids for treatment of diabetes | |
AU2002231206A1 (en) | Treatment of depression | |
AU2002236781A1 (en) | Treatment for snoring | |
AU2002217447A1 (en) | Apparatus for lipolysis for aesthetic treatment | |
AU7750100A (en) | Method for the treatment of obesity | |
AU2001245414A1 (en) | Treatment of allergies | |
AU2002225327A1 (en) | Apparatus for aesthetic treatment | |
AU2001262177A1 (en) | Method of treatment | |
AUPR731901A0 (en) | Method of treatment | |
AU2001281465A1 (en) | Treatment of rosacea | |
AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
AU2001253560A1 (en) | Methods of treatment | |
AU2002212876A1 (en) | Method for integrated water treatment | |
AU2002323430A1 (en) | Methods of treating obesity | |
GB0001861D0 (en) | Method for the treatment of obesity | |
AUPR213000A0 (en) | Method of treatment | |
AUPQ949500A0 (en) | Method of treatment |